Bayerische Motoren Werke ADR (BMWYY)

Dolby (DLB) Q2 2026 Earnings Call Transcript

Audio and video technology company Dolby Laboratories (NYSE:DLB) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 7.1% ye...

Mooresville, NC - AutoTechnic reinforces its position as a dedicated German automotive specialist, focusing exclusively on BMW, MINI, and Mercedes-Benz vehicles. Located in downtown Mooresville, AutoTechnic provides comprehensive repair and maintenance solutions designed to support long-term vehicle performance and reliability.

New research has mapped how breast tissues change as women age. The findings help to explain why breast cancer cases are higher in older women, and this could potentially help in finding new ways to fight this disease.

During a recent House hearing conducted by the Ways and Means Committee, hospital CEOs were put on the spot over the inexplicably high facility fees that they charge. GOP members of the committee accused the hospitals of taking advantage of the healthcare system and of overcharging patients.

Telomir Pharmaceuticals (NASDAQ: TELO), a clinical-stage biotechnology company, announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for Telomir-Zn to treat advanced or metastatic triple-negative breast cancer. The clearance enables initiation of a first-in-human Phase 1/2 clinical trial designed to evaluate safety, dosing and preliminary antitumor activity, supported by preclinical pharmacology, toxicology and biomarker data as the Company advances its lead candidate toward clinical development.

Beijing, China, April 30, 2026 -- At Auto China 2026, Reach officially unveiled its full-stack product portfolio designed to accelerate the intelligent evolution of AI vehicles. Industry leaders and experts, along with executives and representatives from Honda, Toyota, FAW, Geely, GAC, Dongfeng Voyah, FAW Jiefang, BMW, Volkswagen CARIAD, Chery, Nissan, Mazda, Hitachi Astemo, Bosch, UAES, ZTE Microelectronics and other global OEMs and industry partners, visited the booth for in-depth discussions on the future of AI-powered mobility and intelligent vehicle evolution.

Wuhu, Anhui, China, April 30, 2026 -- LUXEED International successfully held the “LUXEED Prototype Private Preview”, an exclusive session under the brand’s premium themed campaign ‘“I” Drive, You Enjoy’, from April 25 to 26. The event brought together over 300 key dealers from more than a dozen countries and regions across Europe, right-hand-drive markets, and the Middle East, to explore LUXEED’s upcoming product portfolio and discuss new opportunities for the brand’s global development.

ARMADALE, WA - April 29, 2026 - Triggs Garage, a European vehicle specialist workshop based in Armadale, is bringing decades of European-born automotive expertise to Perth drivers of BMW, Audi, Mercedes-Benz, Volkswagen, and other European marques. Founded in the United Kingdom in 1977 and established in Western Australia in 2018, the workshop combines deep manufacturer-trained knowledge with current-generation diagnostic equipment, giving Perth owners of premium European cars a dealer-level alternative to franchise servicing.

Limo SF VIP ((888) 888-0195) has expanded their offerings to include luxury sedan chauffeur services in the San Francisco area.

ARMR Sciences completed a private placement financing with strategic and institutional investors, with Joseph Gunnar & Co., LLC acting as placement agent, as the company advances toward human trials for its fentanyl vaccine. Backed by the U.S. Department of War, the vaccine is designed to prevent fatal overdoses and address threats from substances such as fentanyl, supporting continued development and clinical progression.

Most cancer patients report cognitive deterioration, such as memory loss and difficulty concentrating as they undergo cancer treatments like chemotherapy and radiation. This has widely come to be known as “ chemo brain .” Recent research suggests that exercising and taking a common OTC drug, ibuprofen, can alleviate these cognitive effects of cancer therapy.

NextPlat (NASDAQ: NXPL, NXPLW) announced it has regained compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) following receipt of a compliance letter from The Nasdaq Stock Market LLC on April 27, 2026. Nasdaq determined the Company’s shares maintained a closing bid price of at least $1.00 for 10 consecutive business days from April 13, 2026 to April 24, 2026, and confirmed the matter is now closed, with NextPlat continuing to trade on The Nasdaq Capital Market under the ticker NXPL.

Cardiovascular diagnostics are undergoing a transformation as advances in molecular science and artificial intelligence (“AI”) converge to deliver more precise, individualized insights from minimally invasive tests. Cardio Diagnostics Holdings (NASDAQ: CDIO) is at the forefront of this shift, developing a proprietary platform that integrates epigenetic and genetic biomarkers with AI to generate personalized cardiovascular risk assessments from a simple blood sample.

Last fall, Johns Hopkins School of Nursing through its Institute for Policy Solutions conducted a survey on health inequities and the full report from that survey was released weeks ago. The findings of that poll offer valuable insights that policymakers and all stakeholders need to weigh while making decisions impacting the health of Americans.

Scinai Immunotherapeutics (NASDAQ: SCNI) announced it has entered into a securities purchase agreement with institutional and accredited investors for the sale of 5,208,333 ADSs at $0.48 per ADS, along with accompanying Series A and Series B warrants, and separately executed a warrant inducement agreement with an existing investor. The combined transactions are expected to generate approximately $2.61 million in gross proceeds, with closing anticipated on or about April 27, 2026, subject to customary conditions. The company said proceeds will support expansion of its CDMO platform, advancement of customer programs and continued investment in its immunotherapy pipeline.

INGLEWOOD, CA - April 21, 2026 - Car Lux Inc is drawing attention to a retail model built around inspected inventory, financing access, and two showroom locations in South Los Angeles. With locations on South La Brea Avenue in Inglewood and Hawthorne Boulevard in Lennox, Car Lux Inc is positioned to serve shoppers seeking luxury vehicles, SUVs, and pre owned cars through a local shopping process rather than a long regional search. Current site information also points to more than 300 vehicles across two locations, along with online tools for pre-qualification, credit applications, and test-drive scheduling.

Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has residual bladder cancer after they have undergone surgery to remove the tumor. This test may also detect whether immunotherapy treatment administered after surgery has been effective or residual bladder cancer remains.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a positive Discipline Review Letter from the FDA Office of Generic Drugs covering quality-related aspects of its ketamine ANDA, with only minor administrative updates requested. The company also reported a supportive meeting with FDA leadership aligned with federal priorities to accelerate treatments for severe mental illness, reinforcing expectations for potential approval of its preservative-free ketamine product in summer 2026.

Nutriband (NASDAQ: NTRB) announced that CEO and Co-Founder Gareth Sheridan appeared on the Jack Neel Podcast to discuss the opioid crisis and the company’s AVERSA(TM) abuse-deterrent transdermal technology. The episode outlines how AVERSA(TM) is designed to reduce misuse, diversion, and accidental exposure of high-risk drugs such as fentanyl, while maintaining patient access, and is supported by a broad global patent portfolio.

Moorestown, NJ -InTown Auto Care - European Automotive Repair: Audi, BMW, Land Rover, Mercedes, Mini, Porsche, Volkswagen, a trusted name in European automotive repair, has established itself as a premier destination for car owners in Moorestown and beyond who seek expert vehicle service. Specializing in brands like Audi, BMW, Land Rover, Mercedes, Mini, Porsche, and Volkswagen, the Auto repair shop prides itself on delivering top-notch service with an unwavering commitment to excellence.

IONCHI, the joint venture between BMW and Mercedes-Benz on high-power charging services, announced today that SERES will join the company as an equal shareholder. Through this shareholding investment, AITO, the premium brand of the SERES Group, will support the development of IONCHI’s premium charging infrastructure. With this addition, IONCHI continues to provide premium charging services through advanced technology and digital services to all eligible vehicles, while offering exclusive charging experiences to the customers of BMW, AITO and Mercedes-Benz. The expanded three-party partnership marks the beginning of a new chapter for the premium charging network, enabling further growth and broader customer reach. Each of the three shareholders will hold a 33.3% stake in the joint venture.

Oncotelic Therapeutics (OTCQB: OTLC) was highlighted in a BioMedWire editorial examining how advancing drug pipelines are increasingly being recognized as measurable financial assets under U.S. GAAP, reflecting a broader shift in biotech valuation. The company was noted for leveraging its diversified pipeline and strategic holdings, including a 45% stake in GMP Bio, recently valued at more than $1 billion, as an example of how scientific progress and proximity to commercialization can directly enhance balance sheet value and investor perception.

Primary and metastatic central nervous system (CNS) tumors can have extraordinary biological and anatomical complexity, and these tumors can be hard to identify using traditional imaging or histopathology analysis. Molecular analysis has emerged as a major way to identify these tumors and help medical teams plan how best to help those diagnosed with these cancers.

Beijing, China, April 21, 2026 -- IONCHI, the joint venture between BMW and Mercedes-Benz on high-power charging services, announced today that SERES will join the company as an equal shareholder. Through this shareholding investment, AITO, the premium brand of the SERES Group, will support the development of IONCHI’s premium charging infrastructure. With this addition, IONCHI continues to provide premium charging services through advanced technology and digital services to all eligible vehicles, while offering exclusive charging experiences to the customers of BMW, AITO and Mercedes-Benz. The expanded three-party partnership marks the beginning of a new chapter for the premium charging network, enabling further growth and broader customer reach. Each of the three shareholders will hold a 33.3% stake in the joint venture.